Celemics is a Next Generation Sequencing (NGS) full solution provider based on target enrichment technology. We confidently offer custom target enrichment panels and high-quality pre-set panels, covering fields such as Inherited Diseases, Oncology, Immunology, and Pathogen Diagnostics. With 13 years of experience, we will provide the best solution for your Targeted Sequencing. [Products/Services] OncoRisk (Hereditary Cancer) | CancerScreen (Somatic Cancer) | Custom Target Enrichment Panel | Whole Exome Sequencing | Clinical Exome Sequencing | BRCA 1/2 | PharmacoScreen | Comprehensive Respiratory Virus | Agrigenomics
View Top Employees from Celemics| Website | https://www.celemics.com |
| Revenue | $11 million |
| Employees | 39 (38 on RocketReach) |
| Founded | 2010 |
| Phone | (949) 627-8880 |
| Technologies |
JavaScript,
HTML,
Twitter
+19 more
(view full list)
|
| Industry | Biotechnology Research, Business Services General, Laboratory Services (Healthcare), NGS, Business Services, Biotechnology, Target Sequencing, Antibody Library Sequencing, Immune Profiling |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular Celemics employee's phone or email?
Celemics Questions
The Celemics annual revenue was $11 million in 2024.
Hyoki Kim is the Co-Founder and Chief Executive Officer of Celemics.
38 people are employed at Celemics.
The NAICS codes for Celemics are [325, 3254, 32].
The SIC codes for Celemics are [283, 28].
Top Celemics Employees
Related Companies
